Paul S. Kingma, MD, PhD
- Director, Bronchopulmonary Dysplasia (BPD) Center
- Associate Professor, UC Department of Pediatrics
- paul.kingma@cchmc.org
- Board Certified
About
Biography
Paul S. Kingma, MD, PhD, serves as an attending physician in the Cincinnati Children’s NICU and as neonatal director of the Cincinnati Fetal Center. Dr Kingma leads several basic science and translation research projects that focus on four primary goals.
The first goal is to improve our understanding of pathogenesis of congenital diaphragmatic hernia (CDH). To this end, Dr. Kingma’s laboratory is developing novel methods for measuring lung injury in CHD infants and he has advanced the use of airway pressure release ventilation as a method of reducing lung injury in infants with CDH. In addition, as part of a collaboration with Dr. Jason Woods, Dr. Kingma is using novel MRI-based methods to measure lung growth and function in CDH infants.
The second goal is to improve our understanding of the formation, repair and prognosis of tracheal esophageal (TE) defects. Dr. Kingma is using novel MRI techniques for evaluating tracheal and esophageal morphology in infants with TE defects. In addition, Dr. Kingma is leading an effort to gather detailed anatomic, genetic and clinical outcome data on a large cohort of patients with TE defects in order enhance diagnosis, predict patients at risk for complications, and ultimately improve treatment.
The third goal is to develop effective clinical management strategies to prevent and treat intestinal dysfunction and feeding intolerance in infants with gastroschisis. Dr. Kingma is currently leading a Gerber Foundation funded study that is using MRI to quantify intestinal factors that lead to enteral feeding intolerance.
The final goal of is to improve our understanding of the molecular pathogenesis of neonatal lung injury. Specifically, Dr. Kingma is evaluating the role of the Surfactant Protein D (SP-D) and the pulmonary innate immune system. In addition, Dr. Kingma is part of a Cincinnati Children's Hospital Medical Center collaboration that is developing SP-D as a therapeutic agent designed to improve surfactant function and reduce lung injury in premature infants.
BS: Calvin College, MI, 1992.
MD: Vanderbilt University, TN, 2000.
PhD: Vanderbilt University, TN, 2000.
Residency: Cincinnati Children's Hospital Medical Center, 2003.
Fellowship: Cincinnati Children's Hospital Medical Center, 2005.
Interests
Neonatology; fetal care; neonatal care of infants with congenital malformations including congenital diaphragmatic hernia, tracheal-esophageal defects and gastroschisi
Services and Specialties
Congenital Diaphragmatic Hernia, Newborn Intensive Care NICU, Neonatology, Perinatal, Bronchopulmonary Dysplasia BPD
Interests
Innate immune systems; surfactant protein D; Neonatal lung growth; genetic basis of congenital malformations
Research Areas
Neonatology, Pulmonary Biology
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Feeding Tolerance, Intestinal Motility, and Superior Mesenteric Artery Blood Flow in Infants with Gastroschisis. Neonatology: foetal and neonatal research. 2020; 117:95-101.
Evaluation of Lung Injury in Infants with Congenital Diaphragmatic Hernia. Journal of Pediatric Surgery. 2019; 54:2443-2447.
Neonatal lung growth in congenital diaphragmatic hernia: evaluation of lung density and mass by pulmonary MRI. Pediatric Research. 2019; 86:635-640.
Pre- and post-operative visualization of neonatal esophageal atresia/tracheoesophageal fistula via magnetic resonance imaging. Journal of Pediatric Surgery Case Reports. 2018; 29:5-8.
Evaluation of Neonatal Lung Volume Growth by Pulmonary Magnetic Resonance Imaging in Patients with Congenital Diaphragmatic Hernia. The Journal of Pediatrics. 2017; 188:96-102.e1.
Intravenous surfactant protein D inhibits lipopolysaccharide-induced systemic inflammation. Annals of Anatomy. 2023; 247:152048.
Fetal Tracheal Occlusion for Congenital Diaphragmatic Hernia. NeoReviews.org. 2023; 24:e263-e269.
Magnetic Resonance Imaging-Based Evaluation of Anatomy and Outcome Prediction in Infants with Esophageal Atresia. Neonatology: foetal and neonatal research. 2023; 120:185-195.
Quantitative cardiopulmonary magnetic resonance imaging in neonatal congenital diaphragmatic hernia. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2022; 52:2306-2318.
Identification and validation of candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas. HGG Advances. 2022; 3:100107.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2023 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey